Last reviewed · How we verify
Post-Op Ocular Inflammation
Approved treatments
- Yellox · University of Trieste
- Lotemax · Bausch Health
- Fml · AbbVie
- Voltaren · Hisamitsu Pharmaceutical Co., Inc
- Medrifar · AbbVie
- Cortone
- Tham · Pfizer
- Lotemax · Tufts Medical Center
- Decadron · Generic (originally Merck)
- Durezol · Novartis
Durezol works by binding to glucocorticoid receptors in the body, mimicking the effects of cortisol to reduce inflammation. - Cortef · Generic (originally Merck/Upjohn)
- Toradol
- Flarex · Harrow Health
- Xibrom · Bausch Health
Xibrom works by blocking the production of prostaglandins, which are hormone-like substances that cause pain and inflammation. - Arthrotec · Pfizer
- Benzododecinium
- Nevanac · Harrow Health
Nevanac works by inhibiting the enzyme prostaglandin G/H synthase 2, which is involved in producing prostaglandins that cause pain and inflammation. - NEPA · Harrow Eye
- Cortisol · University of Zurich
- Prelone · Generic (originally Schering)
- Xibrom · Bp Consulting, Inc
- prednisolon · Hannover Medical School
- Nevanac · Santa Casa de Misericordia de Santos
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Post-Op Ocular Inflammation patent landscape — cliff calendar, originator estates, attackable patents
- Post-Op Ocular Inflammation treatment landscape brief
- Post-Op Ocular Inflammation treatment updates RSS
Frequently asked questions about Post-Op Ocular Inflammation
What drugs treat Post-Op Ocular Inflammation?
Tracked treatments include Yellox, Lotemax, Fml, Voltaren, Medrifar, Cortone, Tham, Decadron.
What is the treatment for Post-Op Ocular Inflammation?
Standard treatment for Post-Op Ocular Inflammation includes Yellox, Lotemax, Fml, Voltaren, Medrifar. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Post-Op Ocular Inflammation patent cliff · Post-Op Ocular Inflammation CI report
- Treatment: Yellox · University of Trieste
- Treatment: Lotemax · Bausch Health
- Treatment: Fml · AbbVie
- Treatment: Voltaren · Hisamitsu Pharmaceutical Co., Inc
- Treatment: Medrifar · AbbVie
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing